// App-Quantinova.ai

P-169 : Feasibility of gemcitabine plus cisplatin as neo-adjuvant in cholangiocarcinoma patients prior to liver transplantation

Researchers

Presenter

  • A. Esmail

Principal Investigators

  • J. Xu

  • G. Umoru

  • H. Al-Rawi

  • A. Saharia

  • M. Abdelrahim

Medical Centers

  • Houston Methodist Hospital, Houston, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Advanced biliary tract carcinoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Gemcitabine

  • Cisplatin

Outcome

  • N/A

Study Design

  • Prospective

  • Feasibility

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved